Affordable Access

Publisher Website

Successful Treatment of Post-COVID-19 ADHD-like Syndrome: A Case Report.

Authors
  • Victor, Marcelo Moraes1
  • Müller Haas, Letícia1
  • Grevet, Eugenio Horácio1
  • Rohde, Luís Augusto1, 2, 3
  • 1 Federal University of Rio Grande do Sul, Porto Alegre Brazil. , (Brazil)
  • 2 National Institute of Developmental Psychiatry for Children and Adolescents (CNPq), Sao Paulo, Brazil. , (Brazil)
  • 3 UniEduK, Jaguariúna, Brazil. , (Brazil)
Type
Published Article
Journal
Journal of Attention Disorders
Publisher
SAGE Publications
Publication Date
Aug 01, 2023
Volume
27
Issue
10
Pages
1092–1098
Identifiers
DOI: 10.1177/10870547231168338
PMID: 37052263
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Despite inattention being one of the most common symptoms of Post-COVID-19 Syndrome (PCS), there is a gap in the literature regarding its treatment. This report presents a case of attentional symptoms and fatigue that emerged after the SARS-CoV-2 infection. The symptoms were similar to ADHD in adults, although the 61-year-old patient had never experienced inattention symptoms before. The patient was initially treated with Methylphenidate and then Lisdexamfetamine. Both were adapted to the needs and treatment response presented by the patient. After several changes in the therapeutic regimen, including the addition of Bupropion, the patient achieved remission of his symptoms. This case highlights the importance of treating PCS inattention and fatigue as an ADHD-like syndrome, despite the evident different etiology of symptoms. It would be necessary to replicate these findings to confirm our results, thus benefiting other patients currently affected by this syndrome.

Report this publication

Statistics

Seen <100 times